000 | 01082 a2200289 4500 | ||
---|---|---|---|
005 | 20250517131437.0 | ||
264 | 0 | _c20190508 | |
008 | 201905s 0 0 eng d | ||
022 | _a1527-7755 | ||
024 | 7 |
_a10.1200/JCO.2016.71.0673 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRini, Brian I | |
245 | 0 | 0 |
_aFuture Challenges for Drug Development in Renal Cell Carcinoma. _h[electronic resource] |
260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _c02 2017 |
||
300 |
_a577-579 p. _bdigital |
||
500 | _aPublication Type: Editorial; Comment | ||
650 | 0 | 4 | _aAnilides |
650 | 0 | 4 | _aCarcinoma, Renal Cell |
650 | 0 | 4 | _aDrug Development |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKidney Neoplasms |
650 | 0 | 4 | _aPyridines |
650 | 0 | 4 | _aSunitinib |
700 | 1 | _aVogelzang, Nicholas J | |
773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 35 _gno. 6 _gp. 577-579 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2016.71.0673 _zAvailable from publisher's website |
999 |
_c26711312 _d26711312 |